{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/entity/KYMR/timeline","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://api.ai-analytics.org/license","usage_info":"https://api.ai-analytics.org/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-23T01:26:25.893Z","methodology_url":"https://api.ai-analytics.org/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9040,"canonical_name":"Kymera Therapeutics, Inc.","cik":"0001815442","uei":null,"lei":null,"duns":null,"ticker":"KYMR"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","open.payments","dol.form5500","hud.housing","irs.bmf"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":141,"clinical":1},"count":100,"timeline":[{"ts":"2026-07-07","kind":"sec.form144","reporter":"Mainolfi Nello","title":"Officer, Director","shares":50000,"usd_value":5950000,"security_title":"Common","approx_sale_date":"2026-07-07","accession_number":"0001969223-26-000769","importance":41.19},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Mainolfi Nello","title":"Chief Executive Officer","shares":50000,"price_per_share":119,"usd_value":5950000,"security_title":"Common Stock","importance":40.95},{"ts":"2026-07-07","kind":"sec.insider.m","reporter":"Mainolfi Nello","title":"Chief Executive Officer","shares":50000,"price_per_share":2.08,"usd_value":104000,"security_title":"Common Stock","importance":15.104},{"ts":"2026-07-02","kind":"sec.form144","reporter":"Mainolfi Nello","title":"Officer, Director","shares":80000,"usd_value":9143200,"security_title":"Common","approx_sale_date":"2026-07-01","accession_number":"0001969223-26-000752","importance":41.82864},{"ts":"2026-07-02","kind":"sec.filing","form_type":"144","title":"144 — Kymera Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001815442/144/0001969223-26-000752","accession_number":"0001969223-26-000752","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — Kymera Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001815442/4/0001193125-26-295088","accession_number":"0001193125-26-295088","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — Kymera Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001815442/4/0001193125-26-295089","accession_number":"0001193125-26-295089","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — Kymera Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001815442/4/0001193125-26-295090","accession_number":"0001193125-26-295090","importance":30},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Mainolfi Nello","title":"Chief Executive Officer","shares":44050,"price_per_share":115.6883,"usd_value":5096070,"security_title":"Common Stock","importance":40.096069615},{"ts":"2026-07-01","kind":"sec.form144","reporter":"NOAH GOODMAN","title":"Officer","shares":3389,"usd_value":388617,"security_title":"Common","approx_sale_date":"2026-07-01","accession_number":"0001950047-26-006765","importance":40.077723326},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Mainolfi Nello","title":"Chief Executive Officer","shares":24105,"price_per_share":114.9555,"usd_value":2771002,"security_title":"Common Stock","importance":37.7710023275},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Mainolfi Nello","title":"Chief Executive Officer","shares":6626,"price_per_share":113.9758,"usd_value":755204,"security_title":"Common Stock","importance":35.7552036508},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Mainolfi Nello","title":"Chief Executive Officer","shares":3336,"price_per_share":116.559,"usd_value":388841,"security_title":"Common Stock","importance":35.388840824},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Goodman Noah","title":"Chief Business Officer","shares":3389,"price_per_share":114.29,"usd_value":387329,"security_title":"Common Stock","importance":35.38732881},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Mainolfi Nello","title":"Chief Executive Officer","shares":1883,"price_per_share":112.8046,"usd_value":212411,"security_title":"Common Stock","importance":35.2124110618},{"ts":"2026-07-01","kind":"sec.filing","form_type":"144","title":"144 — Kymera Therapeutics, Inc. — 2026-07-01","url_slug":"/sec/cik-0001815442/144/0001950047-26-006765","accession_number":"0001950047-26-006765","importance":30},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Mainolfi Nello","title":"Chief Executive Officer","shares":80000,"price_per_share":2.08,"usd_value":166400,"security_title":"Common Stock","importance":15.1664},{"ts":"2026-06-30","kind":"sec.form144","reporter":"BRUCE N. JACOBS","title":"Officer","shares":77109,"usd_value":8429556,"security_title":"Common","approx_sale_date":"2026-06-30","accession_number":"0001950047-26-006647","importance":41.685911176},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Jacobs Bruce N.","title":"Chief Financial Officer","shares":51375,"price_per_share":114.7696,"usd_value":5896288,"security_title":"Common Stock","importance":40.8962882},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Jacobs Bruce N.","title":"Chief Financial Officer","shares":7971,"price_per_share":115.8171,"usd_value":923178,"security_title":"Common Stock","importance":35.9231781041},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Jacobs Bruce N.","title":"Chief Financial Officer","shares":6153,"price_per_share":116.9937,"usd_value":719862,"security_title":"Common Stock","importance":35.7198622361},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Jacobs Bruce N.","title":"Chief Financial Officer","shares":4110,"price_per_share":114.1875,"usd_value":469311,"security_title":"Common Stock","importance":35.469310625},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Jacobs Bruce N.","title":"Chief Financial Officer","shares":3200,"price_per_share":117.7029,"usd_value":376649,"security_title":"Common Stock","importance":35.37664928},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Jacobs Bruce N.","title":"Chief Financial Officer","shares":1700,"price_per_share":111.5671,"usd_value":189664,"security_title":"Common Stock","importance":35.18966407},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Jacobs Bruce N.","title":"Chief Financial Officer","shares":1500,"price_per_share":110.5397,"usd_value":165810,"security_title":"Common Stock","importance":35.16580955},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Jacobs Bruce N.","title":"Chief Financial Officer","shares":1100,"price_per_share":112.7881,"usd_value":124067,"security_title":"Common Stock","importance":35.12406691},{"ts":"2026-06-30","kind":"sec.filing","form_type":"144","title":"144 — Kymera Therapeutics, Inc. — 2026-06-30","url_slug":"/sec/cik-0001815442/144/0001950047-26-006647","accession_number":"0001950047-26-006647","importance":30},{"ts":"2026-06-30","kind":"sec.insider.m","reporter":"Jacobs Bruce N.","title":"Chief Financial Officer","shares":61378,"price_per_share":5.33,"usd_value":327145,"security_title":"Common Stock","importance":15.32714474},{"ts":"2026-06-29","kind":"sec.form144","reporter":"Atlas Venture Fund X, LP","title":"Shareholder","shares":66177,"usd_value":7155057,"security_title":"Common Stock","approx_sale_date":"2026-06-29","accession_number":"0001628280-26-046097","importance":41.431011448},{"ts":"2026-06-29","kind":"sec.form144","reporter":"Atlas Venture Opportunity Fund I, LP","title":"Shareholder","shares":10473,"usd_value":1132341,"security_title":"Common Stock","approx_sale_date":"2026-06-29","accession_number":"0001628280-26-046098","importance":40.226468152},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":19419,"price_per_share":107.76,"usd_value":2092591,"security_title":"Common Stock","importance":37.09259144},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":19093,"price_per_share":107.76,"usd_value":2057462,"security_title":"Common Stock","importance":37.05746168},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":14798,"price_per_share":106.63,"usd_value":1577911,"security_title":"Common Stock","importance":36.57791074},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":14613,"price_per_share":106.63,"usd_value":1558184,"security_title":"Common Stock","importance":36.55818419},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":10848,"price_per_share":108.28,"usd_value":1174621,"security_title":"Common Stock","importance":36.17462144},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":10658,"price_per_share":108.28,"usd_value":1154048,"security_title":"Common Stock","importance":36.15404824},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":7968,"price_per_share":109.75,"usd_value":874488,"security_title":"Common Stock","importance":35.874488},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":7833,"price_per_share":109.75,"usd_value":859672,"security_title":"Common Stock","importance":35.85967175},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":7723,"price_per_share":110.67,"usd_value":854704,"security_title":"Common Stock","importance":35.85470441},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":7602,"price_per_share":110.67,"usd_value":841313,"security_title":"Common Stock","importance":35.84131334},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":5549,"price_per_share":105.78,"usd_value":586973,"security_title":"Common Stock","importance":35.58697322},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":5471,"price_per_share":105.78,"usd_value":578722,"security_title":"Common Stock","importance":35.57872238},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":3024,"price_per_share":107.76,"usd_value":325866,"security_title":"Common Stock","importance":35.32586624},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":2698,"price_per_share":107.76,"usd_value":290736,"security_title":"Common Stock","importance":35.29073648},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":2318,"price_per_share":106.63,"usd_value":247168,"security_title":"Common Stock","importance":35.24716834},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":2133,"price_per_share":106.63,"usd_value":227442,"security_title":"Common Stock","importance":35.22744179},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":1688,"price_per_share":108.28,"usd_value":182777,"security_title":"Common Stock","importance":35.18277664},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":1498,"price_per_share":108.28,"usd_value":162203,"security_title":"Common Stock","importance":35.16220344},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":1239,"price_per_share":109.75,"usd_value":135980,"security_title":"Common Stock","importance":35.13598025},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":1199,"price_per_share":110.67,"usd_value":132693,"security_title":"Common Stock","importance":35.13269333},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":1104,"price_per_share":109.75,"usd_value":121164,"security_title":"Common Stock","importance":35.121164},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":1078,"price_per_share":110.67,"usd_value":119302,"security_title":"Common Stock","importance":35.11930226},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":934,"price_per_share":111.2,"usd_value":103861,"security_title":"Common Stock","importance":35.1038608},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":907,"price_per_share":111.2,"usd_value":100858,"security_title":"Common Stock","importance":35.1008584},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":848,"price_per_share":105.78,"usd_value":89701,"security_title":"Common Stock","importance":35.08970144},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":770,"price_per_share":105.78,"usd_value":81451,"security_title":"Common Stock","importance":35.0814506},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":157,"price_per_share":111.2,"usd_value":17458,"security_title":"Common Stock","importance":35.0174584},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":130,"price_per_share":111.2,"usd_value":14456,"security_title":"Common Stock","importance":35.014456},{"ts":"2026-06-29","kind":"sec.filing","form_type":"144","title":"144 — Atlas Venture Opportunity Fund I, L.P. — 2026-06-29","url_slug":"/sec/cik-0001759241/144/0001628280-26-046098","accession_number":"0001628280-26-046098","importance":30},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF PARTNERS L P/IL","title":"","shares":837914,"price_per_share":106.5,"usd_value":89237841,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BIOTECHNOLOGY VALUE FUND L P","title":"","shares":837914,"price_per_share":106.5,"usd_value":89237841,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF I GP LLC","title":"","shares":837914,"price_per_share":106.5,"usd_value":89237841,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BIOTECHNOLOGY VALUE FUND II LP","title":"","shares":837914,"price_per_share":106.5,"usd_value":89237841,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF II GP LLC","title":"","shares":837914,"price_per_share":106.5,"usd_value":89237841,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Biotechnology Value Trading Fund OS LP","title":"","shares":837914,"price_per_share":106.5,"usd_value":89237841,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF Partners OS Ltd.","title":"","shares":837914,"price_per_share":106.5,"usd_value":89237841,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF GP HOLDINGS LLC","title":"","shares":837914,"price_per_share":106.5,"usd_value":89237841,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF INC/IL","title":"","shares":837914,"price_per_share":106.5,"usd_value":89237841,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"LAMPERT MARK N","title":"","shares":837914,"price_per_share":106.5,"usd_value":89237841,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF PARTNERS L P/IL","title":"","shares":627597,"price_per_share":106.5,"usd_value":66839081,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BIOTECHNOLOGY VALUE FUND L P","title":"","shares":627597,"price_per_share":106.5,"usd_value":66839081,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF I GP LLC","title":"","shares":627597,"price_per_share":106.5,"usd_value":66839081,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BIOTECHNOLOGY VALUE FUND II LP","title":"","shares":627597,"price_per_share":106.5,"usd_value":66839081,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF II GP LLC","title":"","shares":627597,"price_per_share":106.5,"usd_value":66839081,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Biotechnology Value Trading Fund OS LP","title":"","shares":627597,"price_per_share":106.5,"usd_value":66839081,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF Partners OS Ltd.","title":"","shares":627597,"price_per_share":106.5,"usd_value":66839081,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF GP HOLDINGS LLC","title":"","shares":627597,"price_per_share":106.5,"usd_value":66839081,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF INC/IL","title":"","shares":627597,"price_per_share":106.5,"usd_value":66839081,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"LAMPERT MARK N","title":"","shares":627597,"price_per_share":106.5,"usd_value":66839081,"security_title":"Common Stock, $0.0001 par value","importance":75},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Booth Bruce","title":"","shares":231007,"price_per_share":108.14,"usd_value":24981097,"security_title":"Common Stock","importance":59.981096980000004},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF PARTNERS L P/IL","title":"","shares":113289,"price_per_share":106.5,"usd_value":12065279,"security_title":"Common Stock, $0.0001 par value","importance":47.0652785},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BIOTECHNOLOGY VALUE FUND L P","title":"","shares":113289,"price_per_share":106.5,"usd_value":12065279,"security_title":"Common Stock, $0.0001 par value","importance":47.0652785},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF I GP LLC","title":"","shares":113289,"price_per_share":106.5,"usd_value":12065279,"security_title":"Common Stock, $0.0001 par value","importance":47.0652785},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BIOTECHNOLOGY VALUE FUND II LP","title":"","shares":113289,"price_per_share":106.5,"usd_value":12065279,"security_title":"Common Stock, $0.0001 par value","importance":47.0652785},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF II GP LLC","title":"","shares":113289,"price_per_share":106.5,"usd_value":12065279,"security_title":"Common Stock, $0.0001 par value","importance":47.0652785},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Biotechnology Value Trading Fund OS LP","title":"","shares":113289,"price_per_share":106.5,"usd_value":12065279,"security_title":"Common Stock, $0.0001 par value","importance":47.0652785},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF Partners OS Ltd.","title":"","shares":113289,"price_per_share":106.5,"usd_value":12065279,"security_title":"Common Stock, $0.0001 par value","importance":47.0652785},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF GP HOLDINGS LLC","title":"","shares":113289,"price_per_share":106.5,"usd_value":12065279,"security_title":"Common Stock, $0.0001 par value","importance":47.0652785},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF INC/IL","title":"","shares":113289,"price_per_share":106.5,"usd_value":12065279,"security_title":"Common Stock, $0.0001 par value","importance":47.0652785},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"LAMPERT MARK N","title":"","shares":113289,"price_per_share":106.5,"usd_value":12065279,"security_title":"Common Stock, $0.0001 par value","importance":47.0652785},{"ts":"2026-06-26","kind":"sec.form144","reporter":"Atlas Venture Opportunity Fund I, LP","title":"Shareholder","shares":57451,"usd_value":6690743,"security_title":"Common Stock","approx_sale_date":"2026-06-26","accession_number":"0001628280-26-045807","importance":41.338148692},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF PARTNERS L P/IL","title":"","shares":51858,"price_per_share":106.5,"usd_value":5522877,"security_title":"Common Stock, $0.0001 par value","importance":40.522877},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BIOTECHNOLOGY VALUE FUND L P","title":"","shares":51858,"price_per_share":106.5,"usd_value":5522877,"security_title":"Common Stock, $0.0001 par value","importance":40.522877},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF I GP LLC","title":"","shares":51858,"price_per_share":106.5,"usd_value":5522877,"security_title":"Common Stock, $0.0001 par value","importance":40.522877},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BIOTECHNOLOGY VALUE FUND II LP","title":"","shares":51858,"price_per_share":106.5,"usd_value":5522877,"security_title":"Common Stock, $0.0001 par value","importance":40.522877},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF II GP LLC","title":"","shares":51858,"price_per_share":106.5,"usd_value":5522877,"security_title":"Common Stock, $0.0001 par value","importance":40.522877},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Biotechnology Value Trading Fund OS LP","title":"","shares":51858,"price_per_share":106.5,"usd_value":5522877,"security_title":"Common Stock, $0.0001 par value","importance":40.522877},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF Partners OS Ltd.","title":"","shares":51858,"price_per_share":106.5,"usd_value":5522877,"security_title":"Common Stock, $0.0001 par value","importance":40.522877},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF GP HOLDINGS LLC","title":"","shares":51858,"price_per_share":106.5,"usd_value":5522877,"security_title":"Common Stock, $0.0001 par value","importance":40.522877},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"BVF INC/IL","title":"","shares":51858,"price_per_share":106.5,"usd_value":5522877,"security_title":"Common Stock, $0.0001 par value","importance":40.522877}]}